Related Experiment Video

Updated: Mar 26, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

[STRATEGY FOR THE TREATMENT OF UNRESECTABLE LUNG CANCER]

Kenji Suzuki

    Nihon Geka Gakkai Zasshi
    |February 6, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    429
    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
    08:54

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

    Published on: May 8, 2018

    15.2K

    Related Experiment Videos

    Last Updated: Mar 26, 2026

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
    04:04

    Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

    Published on: February 12, 2017

    11.1K
    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
    11:17

    Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

    Published on: February 27, 2026

    429
    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
    08:54

    Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

    Published on: May 8, 2018

    15.2K

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    3.9K
    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    3.9K
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    9.1K
    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against...
    9.1K

    Articles linked to this work by shared authors, journal, and citation graph.

    Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor.

    Biochemical and biophysical research communications·2015

    Myocardial 14-3-3η protein protects against mitochondria mediated apoptosis.

    Cellular signalling·2015

    Development of MRI-powered modular robotic system.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2015

    Clinical Outcomes of SMART Versus Luminexx Nitinol Stent Implantation for Aortoiliac Artery Disease: A Propensity Score-Matched Multicenter Study.

    Angiology·2014

    Two-year life expectancy in patients with critical limb ischemia.

    JACC. Cardiovascular interventions·2014

    Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice.

    International immunopharmacology·2014

    [IMPACT ON PROMOTION OF A MULTIDISCIPLINARY TEAM APPROACH FOR CANCER TREATMENT BY THE MEXT PROGRAMS OF “HUMAN RESOURCE DEVELOPMENT PLAN” AND “PROMOTION PLAN FOR THE PLATFORM OF HUMAN RESOURCE DEVELOPMENT FOR CANCER”].

    Nihon Geka Gakkai zasshi·2018

    [MULTIDISCIPLINARY CARE FOR PATIENTS WITH BREAST CANCER].

    Nihon Geka Gakkai zasshi·2018

    [ROLE OF A NUTRITION SUPPORT TEAM FOR SURGICAL PATIENTS].

    Nihon Geka Gakkai zasshi·2018

    [INFECTION PREVENTION AND CONTROL BY AN INFECTION CONTROL TEAM].

    Nihon Geka Gakkai zasshi·2018

    [PERIOPERATIVE ORAL MANAGEMENT FOR ESOPHAGEAL CANCER AND LUNG CANCER SURGERY].

    Nihon Geka Gakkai zasshi·2018

    [PERIOPERATIVE TEAM COOPERATION IN OKAYAMA UNIVERSITY HOSPITAL].

    Nihon Geka Gakkai zasshi·2018

    [Evaluation of tolerability and cognitive safety of trospium chloride in the treatment of overactive bladder: a systematic review and meta-analysis].

    Urologiia (Moscow, Russia : 1999)·2026

    [Innovative approaches to carboxyperitoneum creation: experimental developments and clinical perspectives].

    Urologiia (Moscow, Russia : 1999)·2026

    [Risk factors of postoperative urinary retention in patients with intradural extramedullary spinal cord tumors].

    Urologiia (Moscow, Russia : 1999)·2026

    [Complex therapy of chronic bacterial prostatitis using the immunomodulatory drug sodium aminodihydrophthalazinedione].

    Urologiia (Moscow, Russia : 1999)·2026

    Real-world treatment patterns and outcomes in metastatic clear cell renal cell carcinoma following immune checkpoint inhibitor progression (2018-2023).

    The oncologist·2026

    Bronchial stump re-resection for carcinoid tumor recurrence after left pneumonectomy: Case report.

    Turk gogus kalp damar cerrahisi dergisi·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us